Life Science startup ecosystem
We track 5 organisations in this sector across 1+ countries.
Showing 5 of 5 Life Science
Countries in this sector
Sectors alongside this one
Life Science results
-
Accelerace
Accelerace is Denmark's longest-running accelerator and pre-seed investor, founded in 2008 to help early-stage teams validate products, refine go-to-market strategy, and access investors. The program runs multiple tracks across general tech, life science, and sustainability, and pairs founders with a large mentor network. Accelerace also invests small tickets in selected teams and helps them prepare for follow-on funding. It has supported 800+ Nordic startups and remains a core launchpad in the Danish ecosystem.
-
BioInnovation Institute (BII)
BioInnovation Institute is a life science incubator backed by the Novo Nordisk Foundation that helps researchers and founders turn biotech and health innovations into venture ready companies. Based in Copenhagen, BII provides lab space, grant funding, expert business support, and access to investors for projects in therapeutics, diagnostics, and industrial biotech. It runs programs for both idea stage research and early startups, de risking science heavy ventures before they seek larger capital. BII is a central node in the Danish life science startup pipeline.
-
ELPIS Leadership Programme
Organizes executive education courses focused on leading the bio-revolution across life science sectors. Based in Lyngby, Denmark, ELPIS offers leadership development programs for biotech and pharma professionals, bringing together industry executives, researchers, and entrepreneurs to discuss commercialization strategies and emerging trends in biotechnology.
-
Lead the Bio Revolution Across Life Science Course 2026
Course designed to equip leaders with insights and strategies for navigating and driving innovation in the life science bio-revolution. Focuses on emerging trends and leadership challenges in the sector.
-
Novo Holdings
Novo Holdings is the investment arm of the Novo Nordisk Foundation and the largest life science investor in Denmark. It backs biotech, medtech, and health innovation across seed, venture, and growth stages while also managing the foundation's long term ownership in Novo Nordisk and Novozymes. The firm provides patient capital, deep scientific expertise, and global networks for founders building therapies, diagnostics, and industrial biotech solutions. Novo Holdings is a cornerstone of the Danish life science ecosystem.
